|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7028 | (2006.01) |
| A61K 39/008 | (2006.01) | ||
| A61K 39/04 | (2006.01) | ||
| A61K 39/145 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 2664332 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13172042.7 |
| Date of filing the European patent application | 2009-05-22 | |
| (97) | Date of publication of the European application | 2013-11-20 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-29 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 154663 | 2008-05-22 | US | |
| 134127 | 2008-06-05 | US | |
| 351710 | 2009-01-09 | US |
| (72) |
REED, Steven G., US
CARTER, Darrick, US
|
| (73) |
Infectious Disease Research Institute,
1616 Eastlake Ave. E Suite 400, Seattle, WA 98102,
US
|
| (54) | Vaccine composition containing synthetic adjuvant |
| Vaccine composition containing synthetic adjuvant |